Benzinga | Aug 5, 2020 07:59AM EDT

T2 Biosystems Announces Withdrawal Of Proxy Statement Proposal To Amend Its Certificate Of Incorporation To Authorize A Possible Reverse Stock Split

LEXINGTON, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that its Board of Directors has decided it will not seek authority from the stockholders at the 2020 Annual Meeting ("Annual Meeting") to effect a reverse split of its issued and outstanding shares of common stock and, accordingly, Proposal No. 1 in the Definitive Proxy Statement filed with the Securities and Exchange Commission on June 26, 2020 (the "Proxy Statement") for such authority has been withdrawn from the agenda for the Annual Meeting.